During the past decade, Friends Research Institute conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 6 clinical trials were completed, i.e. on average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Friends Research Institute" #1 sponsor was "National Institute on Drug Abuse (NIDA)" with 25 trials, followed by "Friends Research Institute, Inc." with 7 trials sponsored, "University of California, Los Angeles" with 7 trials sponsored, "Catalyst Pharmaceuticals, Inc." with 2 trials sponsored and "Titan Pharmaceuticals" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Friends Research Institute" #1 collaborator was "National Institute on Drug Abuse (NIDA)" with 16 trials as a collaborator, "Friends Research Institute, Inc." with 5 trials as a collaborator, "Baltimore City Health Department" with 1 trials as a collaborator, "Somerset Pharmaceuticals" with 1 trials as a collaborator and "VA Office of Research and Development" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Friends Research Institute" are "Cocaine-Related Disorders" (12 trials), "Opioid-Related Disorders" (12 trials), "Opioid-use Disorder" (4 trials), "Substance-Related Disorders" (4 trials) and "Amphetamine-Related Disorders" (3 trials). Many other conditions were trialed in "Friends Research Institute" in a lesser frequency.

Most popular intervention types in "Friends Research Institute" are "Drug" (38 trials), "Behavioral" (9 trials), "Other" (2 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Buprenorphine" (11 trials), "Buprenorphine/naloxone" (3 trials), "Risperidone" (3 trials), "Selegiline" (3 trials) and "Desipramine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Friends Research Institute" are 46 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Friends Research Institute". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 35 completed trials in Friends Research Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Friends Research Institute, 8 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 6 trials that are defined as “Not Applicable".